Cystic Fibrosis Gastrointestinal Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-08-19
Clinical Trial Update: Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs [Phase 2]
Phase 2 trial evaluating escalating doses of MS1819-SD added to a stable dose of PPEs in cystic fibrosis patients; study completed.